RNA Oxidation Adducts 8-OHG and 8-OHA Change with Ab42 Levels in Late-Stage Alzheimer’s Disease

Scientific articles | 2011 | PLoS ONEInstrumentation
Sample Preparation, GC/MSD
Industries
Clinical Research
Manufacturer
Organomation, Agilent Technologies

Significance of the Topic


Alzheimer’s disease (AD) is defined by the accumulation of amyloid-beta (Ab) peptides and elevated oxidative stress in the aging brain. RNA is particularly vulnerable to oxidative damage, and oxidized nucleosides may alter neuronal protein synthesis and function. Understanding how specific RNA oxidation adducts relate to Ab pathology can uncover early markers and inform disease mechanisms.

Objectives and Study Overview


This study quantified five RNA oxidation adducts across five brain regions from late-stage AD cases and age-matched controls. Using gas chromatography/mass spectrometry, the authors measured 8-hydroxyguanine (8-OHG), 8-hydroxyadenine (8-OHA), 5-hydroxycytosine, fapyadenine, and fapyguanine. They then compared these adduct levels to standard neuropathological markers (diffuse plaques, neuritic plaques, neurofibrillary tangles) and multiple pools of Ab (PBS-, SDS- and formic acid-soluble Ab40 and Ab42), as well as fibrillar Ab via 3H-PIB binding.

Used Instrumentation


  • Gas chromatography/mass spectrometer with selective ion monitoring for derivatized RNA bases.
  • Serial extraction of brain homogenates followed by sandwich ELISA to quantify PBS-, SDS- and formic acid-soluble Ab40 and Ab42, and single-site ELISA for oligomeric Ab.
  • 3H-PIB binding assay to assess fibrillar Ab levels in postmortem tissue.
  • RNA isolation with TRIzol, formic acid hydrolysis, and trimethylsilyl derivatization protocols.

Main Results and Discussion


  • In disease-affected regions (frontal cortex, hippocampus, inferior parietal lobule, superior/middle temporal gyri), 8-OHG levels were significantly decreased in AD, while 8-OHA levels were increased compared to controls. No changes were detected in the cerebellum.
  • No RNA adduct correlated with counts of diffuse plaques, neuritic plaques, or neurofibrillary tangles, indicating that classical histopathology and RNA oxidation are independently modulated.
  • Stepwise multiple regression identified SDS-soluble Ab42 as the strongest negative predictor of 8-OHG decline (adj-R2=0.26, p<0.01), and formic acid-soluble Ab42 as the best positive predictor of 8-OHA increase (adj-R2=0.14, p<0.05).
  • The divergent behavior of 8-OHG and 8-OHA suggests distinct temporal dynamics and potential compensatory effects of Ab aggregates on RNA oxidation; early accumulation of 8-OHG may give way to later peaks in 8-OHA.

Benefits and Practical Applications of the Method


This integrated analytical approach links specific RNA oxidative lesions to discrete Ab42 pools, offering a refined set of molecular markers that complement traditional histopathology. The ability to differentiate SDS- and formic acid-soluble Ab42 in relation to individual RNA adducts can guide biomarker development and improve staging of oxidative stress in AD progression.

Future Trends and Application Possibilities


Extending this work to early or preclinical AD and mild cognitive impairment cohorts could clarify the temporal sequence of RNA oxidation events. Investigating additional RNA modifications, region-specific vulnerabilities, and mechanistic pathways by which Ab aggregates influence nucleotide oxidation will open avenues for targeted neuroprotective therapies and diagnostics.

Conclusion


The study demonstrates a non-linear relationship between late-stage AD Ab42 pools and RNA oxidation adducts. Decreased 8-OHG correlates with SDS-soluble Ab42, while increased 8-OHA aligns with highly insoluble, formic acid-soluble Ab42. These findings underscore the complex interplay between amyloid accumulation and oxidative damage, highlighting the need for comprehensive molecular profiling in AD research.

References


  • Weidner AM, Bradley MA, Beckett TL, Niedowicz DM, Dowling ALS, et al. (2011) RNA Oxidation Adducts 8-OHG and 8-OHA Change with Ab42 Levels in Late-Stage Alzheimer’s Disease. PLoS ONE 6(9): e24930. doi:10.1371/journal.pone.0024930.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Multimodal Chemical Imaging to probe Alzheimer’s Disease Pathology
Multimodal Chemical Imaging to probe Alzheimer’s Disease Pathology
Short-Chain Fatty Acids Analysis in Brain by GC/MS to Determine the Effect of Bioactive Food in a Mouse Model of Alzheimer’s Disease
Exploring the Aβ Plaque microenvironment in Alzheimer's disease model mice by multimodal Lipid-Protein-Histology Imaging on a benchtop mass spectrometer